Silicon Laboratories Inc. filed its Form 10-Q for the quarterly period ended October 3, 2026, reporting a return to profitability in the third quarter after posting a net loss in the same period a year earlier.

Key Highlights

  • Quarterly revenue: Revenues for the three months ended October 3, 2026 were $250,892 thousand, compared with $205,999 thousand for the three months ended October 4, 2025.
  • Third-quarter net income: Net income was $8,851 thousand for the three months ended October 3, 2026, versus a net loss of $9,936 thousand in the prior-year quarter.
  • Nine-month net loss: For the nine months ended October 3, 2026, the company reported a net loss of $17,638 thousand, narrowing from a net loss of $62,223 thousand for the nine months ended October 4, 2025.
  • Total assets: Total assets stood at $1,336,154 thousand as of October 3, 2026, up from $1,269,317 thousand as of January 3, 2026.
  • Cash and equivalents: Cash and cash equivalents were $423,013 thousand at October 3, 2026, compared with $364,222 thousand at January 3, 2026.
  • Shares outstanding: 33,384 thousand shares of common stock were issued and outstanding at October 3, 2026, per the balance sheet.

Silicon Laboratories Q3 2026 Financial Results in Detail

According to the filing, Silicon Laboratories Inc. (NASDAQ:SLAB), a Delaware-incorporated semiconductor company headquartered in Austin, Texas, reported revenues of $250,892 thousand for the three months ended October 3, 2026, an increase from $205,999 thousand in the comparable prior-year quarter. Gross profit for the quarter was $152,578 thousand, compared with $119,019 thousand in the three months ended October 4, 2025. The company reported operating income of $7,951 thousand for the third quarter of 2026, against an operating loss of $12,342 thousand in the year-earlier quarter.

For the nine months ended October 3, 2026, the filing disclosed revenues of $692,581 thousand versus $576,558 thousand for the nine months ended October 4, 2025. Research and development expenses for the nine-month period were $276,784 thousand, while selling, general and administrative expenses were $163,263 thousand, according to the condensed consolidated statements of operations. The operating loss for the nine-month period narrowed to $19,797 thousand from $67,289 thousand in the prior-year period.

The condensed consolidated balance sheet shows total stockholders' equity of $1,125,382 thousand at October 3, 2026, up from $1,094,418 thousand at January 3, 2026. The company disclosed additional paid-in capital of $206,203 thousand and retained earnings of $919,176 thousand at the close of the third quarter. Inventories rose to $133,391 thousand from $95,566 thousand at January 3, 2026, while accounts receivable, net, increased to $79,966 thousand from $64,513 thousand over the same period, the filing stated.

What Was Disclosed

Silicon Laboratories filed a Form 10-Q covering the quarterly period ended October 3, 2026. The filing included condensed consolidated financial statements, management's discussion and analysis, risk factors, and other required disclosures under the Securities Exchange Act of 1934.